3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
28
Myelodysplastic Syndromes
10
Leukemia, Myeloid, Acute
7
Leukemia
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Polycythemia Vera
3
Myeloproliferative Disorders
3
Bronchiolitis Obliterans Syndrome
3
Blast Crisis
3
Neoplasms, Plasma Cell
2
Neoplasms
2
Mastocytosis, Systemic
2
Lymphoma
2
Lymphohistiocytosis, Hemophagocytic
2
Leukemia, Myeloid, Chronic-Phase
2
Hematologic Diseases
2
Graft vs Host Disease
2
Anemia, Aplastic
2
Waldenstrom Macroglobulinemia
1
Vitamin D Deficiency
1
Thrombocytopenia
1
Thalassemia
1
Recurrence
1
Purpura, Thrombocytopenic, Idiopathic
1
Primary Myelofibrosis
1
Piebaldism
1
Philadelphia Chromosome
1
Patient Compliance
1
Pathologic Processes
1
Oligodendroglioma
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Chromosome Aberrations
×
Myeloid
×
Clear all
NCT00461929
2009-02-13
GIST
University Health Network, Toronto
Phase 4
Terminated
68 enrolled